Article Versions Notes

Kania KD, Haręża D, Wilczyński JR, Wilczyński M, Jarych D, Malinowski A, Paradowska E. The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer. Cells. 2022; 11(19):3137. https://doi.org/10.3390/cells11193137

Kania, Katarzyna D., Daria Haręża, Jacek R. Wilczyński, Miłosz Wilczyński, Dariusz Jarych, Andrzej Malinowski, and Edyta Paradowska. 2022. "The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer" Cells 11, no. 19: 3137. https://doi.org/10.3390/cells11193137

Kania, K. D., Haręża, D., Wilczyński, J. R., Wilczyński, M., Jarych, D., Malinowski, A., & Paradowska, E. (2022). The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer. Cells, 11(19), 3137. https://doi.org/10.3390/cells11193137